Washington State University Center for Cannabis Policy, Research, and Outreach
(WSU CCPRO)

In addition to a WSLCB board meeting, a WSU researcher would present their findings on “High-Potency Cannabis” and WSDA staff planned next steps on the hemp program.

Washington state policymakers aiming to rebuild the bulwarks of the highly regulated cannabis market prepared to take new steps to respond to chemically converted hemp cannabinoids.

A leading cannabis researcher went over his work on CBD and THC compounds to leverage the therapeutic potential of the endogenous cannabinoid system in the body.

Panelists from previous talks returned to field questions on identifying and regulating impairing cannabinoids, goals much more difficult to reach for cannabis than for alcohol.

WSLCB staff planned to renew public dialogue about impairing versus non-impairing cannabinoids, providing an opportunity to question how helpful that dichotomy actually is.

A quiet week for cannabis-related policymaking events created space for thoughtful public outreach by members of the University of Washington Center for Cannabis Research.

Legislative leaders of cannabis policy committees talked about a few successes in 2022, and the more numerous failures around medical cannabis, equity, and cannabinoid regulation bills.

Staff briefed on a bill with complex changes to recommended cannabis tax appropriations before testimony emphasized benefits for transparency, social equity, and local governments.

The agency’s top lobbyist reviewed legislative activity, diving deeper into a new cannabinoid regulation bill and work to salvage components of unsuccessful social equity legislation.

A cannabis researcher from WSU went over academic developments around safety, economic development, health, and agriculture before answering attendee questions.